Current Edition

news

Thermo Fisher to buy research contractor PPD in $17B deal

Dive Brief: Thermo Fisher Scientific plans to buy PPD for $17.4 billion to bolster its clinical research service offerings to pharmaceutical and biotech companies.   …

Continue Reading →
news

Cancer biotech Tango to go public through $350M SPAC deal

Dive Brief: Tango Therapeutics plans to become a publicly traded company through a merger with a “blank check” acquisition company that will infuse Tango with …

Continue Reading →
news

Sage, Biogen drug reduces tremors but side effects could limit potential

Dive Brief: An experimental treatment developed by Sage Therapeutics for tremors met its primary goal in a mid-stage clinical study, appearing to significantly reduce shaking …

Continue Reading →
news

GSK stops studies testing closely watched cancer immunotherapy

Dive Brief: GlaxoSmithKline will stop enrolling cancer patients into two mid-stage studies testing a closely watched cancer immunotherapy alongside Merck & Co.’s Keytruda, marking another …

Continue Reading →
news

Moderna watches for ‘waning immunity’ as new data show durable vaccine protection

Dive Brief: Moderna on Tuesday released updated results from the large study that led to U.S. authorization of its coronavirus vaccine, showing the shot’s protective …

Continue Reading →